  |
Lægemiddelstofklassifikation ATC |
M | ||
  |
Antineoplastiske og immunomodulerende midler |
ML | ||
  |
antineoplastiske stoffer |
ML01 | ||
 |
antimetabolitter |
ML01B | ||
 |
pyrimidin-analoger |
ML01BC | ||
 |
cytarabin |
ML01BC01 | ||
 |
fluoruracil |
ML01BC02 | ||
 |
tegafur |
ML01BC03 | ||
 |
carmofur |
ML01BC04 | ||
 |
gemcitabin |
ML01BC05 | ||
 |
capecitabin |
ML01BC06 | ||
 |
azacitidin |
ML01BC07 | ||
 |
decitabin |
ML01BC08 | ||
 |
floxuridin |
ML01BC09 | ||
 |
fluoruracil, kombinationer |
ML01BC52 | ||
 |
tegafur, komb. |
ML01BC53 | ||
 |
decitabin, kombinationer |
ML01BC58 | ||
 |
trifluridin, kombinationer |
ML01BC59 |
TEXT